The formula focuses on strengthening the immune system and can help prevent Alzheimer’s and Parkinson’s disease.
Researchers Viktor Seledtsov, at the Immanuel Kant Baltic Federal University, in Russia, and Alexei von Delwig, of the Innovita Res company, in Lithuania, claim to have created a vaccine against diseases associated with aging. In an article published in the Expert Review of Vaccines, in April, the scientists explain how the vaccine can help prevent atherosclerosis, Alzheimer’s and Parkinson’s.
According to Seledtsov, the most important biological mechanism that limits people’s lifespan is the immune system. “After time immune cells known as T-lymphocytes become more and more autoreactive,” he said in a statement. “To put it simply, they become less aggressive towards foreign pathogens attacking instead of the body’s own tissues. And those attacks are the main cause for autoimmune diseases, usually associated with aging.”
Seledtsov argues that a person’s immune system becomes “hostile” to itself due to a logical reason: the survival of the species. Older people being replaced by young people, from the evolutionary point of view, is an advantage. This causes our cells to decrease their frequency of renewal and beneficial mutations.
With that in mind, the scientists have developed a method of lymphocytic vaccination to fight autoimmune diseases – and the technology has proven clinically effective in the treatment of multiple sclerosis and rheumatoid arthritis.
The scientists also propose the development of an “immunology cell bank”. The idea would be to extract our immunocompetent cells during youth and store them for use in old age. “When injected into an aging body, these cells are able to enhance immunological protection against infection, take control of ‘old’ autoimmune cells and thus prolong a person’s life,” explained Seledtsov.
They do not believe that technologies like this will solve health problems, but, according to them, the method can prolong and improve people’s living standards. “A person’s own cells are the best material for the injection,” said Seledtsov. “And to make this procedure possible, we need the immunology bank.”